Alphatec Announces Commercial Launch of IdentiTi™ TLIF Posterior Oblique Porous Titanium Interbody Implant System
September 25 2019 - 9:00AM
Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a
medical device company dedicated to revolutionizing the approach to
spine surgery, announced today the commercial release of its
IdentiTi TLIF Posterior Oblique Titanium Interbody Implant System
(“IdentiTi PO”) for transforaminal lumbar interbody fusion
procedures. The launch of IdentiTi (TLIF) PO follows
successful alpha evaluations that began in January 2019 and marks
the fifth of six IdentiTi Implant Systems to be launched this year
by ATEC’s Organic Innovation Machine™.
“We continue to execute exceptionally well in
our pursuit of increased market share through clinical
distinction,” said Pat Miles, Chairman and Chief Executive Officer.
“ATEC’s line of IdentiTi Implant Systems brings modernized
technology to our portfolio that improves outcomes and elevates the
sophistication of spine fusion. The latest addition of
IdentiTi (TLIF) PO provides that same sophistication to those
preferring to place oblique implants during a TLIF approach.
It is incredibly exciting to see the investments we’ve made into
innovation reach fruition and begin to accelerate growth
organically.”
IdentiTi TLIF Posterior Oblique Porous
Titanium Interbody Implant System
With a self-distracting bulleted nose, smooth
medial-lateral surfaces, and rounded edges, IdentiTi PO has been
thoughtfully engineered to improve implant insertion while
protecting soft tissue and nerve roots. IdentiTi PO implants are
also uniquely designed with anti-migration teeth and lordosis in
the oblique plane to optimize surgical outcomes.
“IdentiTi PO was designed specifically for an
oblique TLIF implant placement through either a minimally
invasive or open approach,” said Dr. William Taylor, Professor
of Neurosurgery at UC San Diego. “The system has been
engineered with an elegant inserter and a unique
connection feature that facilitates the insert-and-rotate
technique. This emphasis on instrumentation allows the
placement of highly lordotic implants while preserving endplates
during insertion.”
The IdentiTi Line of Implant
Systems
ATEC’s IdentiTi Implant Systems are designed to
provide the biological, biomechanical, and imaging characteristics
that surgeons seek in a fusion construct. The subtractive
process used to manufacture each IdentiTi Implant System results in
more predictable mechanical performance and enhanced imaging
characteristics. IdentiTi implants take advantage of bone’s
affinity for titanium and, because of their porosity, have a
surface roughness that enhances stability. ATEC IdentiTi
implants not only complement the Company’s current suite of PEEK
implants, but also allow ATEC to address the broader market of
surgeons who prefer titanium.
Key features of IdentiTi Implant Systems
include:
- Consistent, fully interconnected
porosity throughout the implant designed to mimic the structure and
porosity of cancellous bone;
- Proprietary pore structure designed
to create surface roughness that facilitates immediate implant
stability and surface adhesion;
- Reduced density (60% porous), which
enhances intraoperative and postoperative imaging;
- Stiffness similar to bone;
- Subtractive manufacturing process,
which creates a consistent porous titanium material that furthers
product performance predictability with consistent and reproducible
interconnected pore sizes; and
- Intuitive, low profile, and
exacting instruments designed to optimize the surgeon experience
and facilitate outstanding patient outcomes.
About Alphatec Holdings,
Inc.
Alphatec Holdings, Inc., through its
wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp
Surgical, Inc., is a medical device company dedicated to
revolutionizing the approach to spine surgery. ATEC designs,
develops and markets spinal fusion technology products and
solutions for the treatment of spinal disorders associated with
disease and degeneration, congenital deformities and trauma. The
Company markets its products in the U.S. via independent sales
agents and a direct sales force.
Additional information can be found at
www.atecspine.com.
Forward Looking Statements
This press release contains "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 that involve risks and uncertainty. Such
statements are based on management's current expectations and are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. The Company cautions investors that
there can be no assurance that actual results will not differ
materially from those projected or suggested in such
forward-looking statements as a result of various factors.
Forward-looking statements include references to the Company’s
planned commercial launches, product introductions and product
integration, surgeon and market acceptance of Company products,
solutions and platforms, and the Company’s ability to deliver key
product features. The important factors that could cause
actual operating results to differ significantly from those
expressed or implied by such forward-looking statements include,
but are not limited to: the uncertainty of success in developing
new products or products currently in the Company’s pipeline;
failure to achieve acceptance of the Company’s products by the
surgeon community; failure to obtain FDA or other
regulatory clearance or approval for new products, or unexpected or
prolonged delays in the process; continuation of favorable third
party reimbursement for procedures performed using the Company’s
products; the Company’s ability to compete with other products and
with emerging new technologies; product liability exposure; patent
infringement claims; and claims related to the Company’s
intellectual property. The words “believe,” “will,” “should,”
“expect,” “intend,” “estimate,” “look forward” and “anticipate,”
variations of such words and similar expressions identify
forward-looking statements, but their absence does not mean that a
statement is not a forward-looking statement. A further list
and description of these and other factors, risks and uncertainties
can be found in the Company's most recent annual report, and
subsequent quarterly and current reports, filed with the U.S.
Securities and Exchange Commission. ATEC disclaims any intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events, or
otherwise, unless required by law.
Investor/Media Contact:
Tina JacobsenInvestor Relations (760)
494-6790ir@atecspine.com
Company Contact:
Jeff BlackChief Financial OfficerAlphatec Holdings, Inc.
ir@atecspine.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/52592d3e-8db4-42f6-8ee3-f89d3b4ad708
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Sep 2023 to Sep 2024